Hypothesis / Aims of Study Extracorporeal shock wave therapy (ESWT) and platelet-rich plasma (PRP) have shown potential in treating erectile dysfunction (ED). Combining these two therapies could potentially amplify their effects and provide a more effective treatment option for ED. …
Background Among the emerging treatments for erectile dysfunction (ED), platelet-rich plasma (PRP), known for its ability to enhance tissue repair and regeneration, stands out as a promising therapeutic approach. In this innovative study, we aimed to assess the efficacy of …
Abstract Purpose: We assessed the safety and efficacy of 2 injections of platelet-rich plasma for treating mild to moderate erectile dysfunction by conducting a prospective, randomized, double-blind, placebo-controlled clinical trial. Materials and methods: Men with mild to moderate erectile dysfunction (International Index …
Abstract We conducted a meta-analysis to evaluate the efficacy of low-intensity extracorporeal shock wave therapy (LI-ESWT) in the treatment of erectile dysfunction (ED). From July 2011 to June 2021, we selected 16 randomized controlled trials (RCTs) including 1,064 participants to …
Introduction: Although the literature on the positive effects of penile low-intensity extracorporeal shockwave therapy is substantial, there are significant differences regarding both the sources of energy and the extracorporeal shockwave therapy (ESWT) devices. Objectives: To provide an overview of the …
Low-intensity extracorporeal shockwave therapy (LI-ESWT) aims to reverse the underlying aberrant mechanisms that lead to the development of erectile dysfunction (ED) and is unlike other commonly used treatment options such as intracavernosal injection (ICI) and phosphodiesterase type 5 inhibitor (PDE-5i) …
INTRODUCTION 1.1 Aims and Objectives The European Association of Urology (EAU) Sexual and Reproductive Health Guidelines aim to provide a comprehensive overview of the medical aspects relating to sexual and reproductive health in adult men. These Guidelines cover the former …